Long term follow up and comparative study of fecal microbiota after vonoprazan and low-dose amoxicillin dual therapy or vonoprazan-based triple therapy for Helicobacter pylori infection
Latest Information Update: 01 Dec 2021
At a glance
- Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; Vonoprazan (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
Most Recent Events
- 01 Dec 2021 Results assessing impact of vonoprazan-based H. pylori therapy on gut microbiota 1-year post-therapy published in the Helicobacter
- 01 Oct 2020 Status changed from recruiting to active, no longer recruiting.
- 06 May 2020 Status changed from not yet recruiting to recruiting.